AAEM case report 4: Guillain–Barré syndrome
Corresponding Author
David H. Weinberg MD
Department of Neurology, Tufts University School of Medicine, St. Elizabeth's Medical Center, Boston, Massachusetts 02135-2907, USA
American Association of Electrodiagnostic Medicine, 421 First Avenue S.W., Suite 300 East, Rochester, MN 55902, USASearch for more papers by this authorCorresponding Author
David H. Weinberg MD
Department of Neurology, Tufts University School of Medicine, St. Elizabeth's Medical Center, Boston, Massachusetts 02135-2907, USA
American Association of Electrodiagnostic Medicine, 421 First Avenue S.W., Suite 300 East, Rochester, MN 55902, USASearch for more papers by this authorAbstract
A 57-year-old woman developed rapidly progressive, symmetric, extremity weakness, facial diplegia, ophthalmoplegia, respiratory insufficiency, and sensory ataxia over a 3-week period. Electrodiagnostic studies were performed on days 6, 13, and 50 following the onset of weakness. Motor nerve conduction abnormalities were the predominant findings. Prolonged motor distal latencies, prolonged or absent F waves, and partial motor conduction blocks were present and form the diagnostic features of an acquired, demyelinating polyneuropathy. Abnormalities in sensory nerve conductions and blink reflexes were also present. Guillain–Barré syndrome was diagnosed prompting the initiation of therapeutic plasma exchange. The patient's clinical status continued to worsen over the next 10 days before stabilizing. Considerable improvement in extremity strength, ocular motility, and respiratory function occurred in the subsequent weeks. Well-planned and well-executed electrodiagnostic studies generate key adjunctive data to the clinical diagnosis of Guillain–Barré syndrome. © 1999 American Association of Electrodiagnostic Medicine. Muscle Nerve 22: 271–281, 1999
REFERENCES
- 1 Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991; 41: 617–618. Medline
- 2Alpers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985; 8: 528–539.
- 3Alpers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrophysiologic features. Muscle Nerve 1989; 12: 435–451. Medline
- 4Asbury AK. Diagnostic considerations in Guillain–Barré syndrome. Ann Neurol 1981; 9(suppl): 1–5. Medline
- 5Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis: its role in the pathogenesis. Medicine 1969; 48: 173–215. Medline
- 6Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for the diagnosis of Guillain–Barré syndrome. Ann Neurol 1978; 3: 565–566. Medline
- 7Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 1990; 27(suppl): S21–S24. Medline
- 8Barohn RJ, Kissel JT, Warmolts A, Mandell JR. Chronic inflammatory polyradiculoneuropathy. Arch Neurol 1989; 46: 878–884. Medline
- 9Berciano J, Coria F, Monton F, Calleja J, Figols J, LaFarga M. Axonal form of Guillain–Barré syndrome: evidence for macrophage-associated demyelination. Muscle Nerve 1993; 16: 744–751. Medline
- 10Berger AR, Busis NA, Logigian EL, Wierzbicka M, Shahani BT. Cervical root stimulation in the diagnosis of radiculopathy. Neurology 1987; 37: 329–332. Medline
- 11Berger AR, Logigian EL, Shahani BT. Reversible proximal conduction block underlies rapid recovery in Guillain–Barré syndrome. Muscle Nerve 1988; 11: 1039–1042. Medline
- 12Bromberg MB, Albers JW. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve 1993; 16: 262–266. Medline
- 13Bril V, Ilse WK, Pearce R, Dhanani A, Sutton D, Kong K. Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain–Barré syndrome. Neurology 1996; 46: 100–103. Medline
- 14Brown WF, Feasby TE. Conduction block and denervation in Guillain–Barré polyneuropathy. Brain 1984; 107: 219–239. Medline
- 15Brown WF, Feasby TE. Sensory evoked potentials in Guillain– Barré polyneuropathy. J Neurol Neurosurg Psychiatry 1984; 47: 288–291. Medline
- 16Brown WF, Feasby TE, Hahn AF. Electrophysiological changes in the acute “axonal” form of Guillain–Barré syndrome. Muscle Nerve 1993; 16: 200–205. Medline
- 17Brown WF, Snow R. Patterns and severity of conduction abnormalities in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 1991; 54: 768–774. Medline
- 18Castro LHM, Ropper AH. Human immune globulin in Guillain–Barré syndrome: worsening during and after treatment. Neurology 1993; 43: 1034–1036. Medline
- 19Cornblath DR, Mellits D, Griffin JW, McKhann GM, Albers JW, Miller RG, Feasby TE, Quaskey SA. Motor conduction studies in Guillain–Barré syndrome: description and prognostic value. Ann Neurol 1988; 23: 354–359. Medline
- 20Cornblath DR. Electrophysiology in the Guillain–Barré syndrome. Ann Neurol 1990; 21(suppl): S17–S20.
- 21Cornblath DR, Sumner AJ, Daube J, Gilliat RW, Brown WF, Parry GJ, Albers JW, Miller RG, Petajan J. Conduction block in clinical practice. Muscle Nerve 1991; 14: 869–871. Medline
- 22Daube JR, Kelly JJ, Martin RA. Facial myokymia with polyradiculoneuropathy. Neurology 1979; 29: 662–669. Medline
- 23de Jager AEJ, Lambregts PCLA, Op de Coul AAW. Cardiovascular disturbances in the Guillain–Barré syndrome. J Auton Nerv Syst 1986; 613: 429–434.
- 24 The Dutch Guillain–Barré Study Group. Treatment of Guillain–Barré syndrome with high-dose immune globulins combined with methylprednisolone. Ann Neurol 1994; 35: 749–752. Medline
- 25Feasby TE. Axonal Guillain–Barré syndrome. Muscle Nerve 1994; 17: 678–679. Medline
- 26Feasby TE, Gilbert JJ, Brown WF. An acute axonal form of Guillain–Barré polyneuropathy. Brain 1986; 109: 1115–1126. Medline
- 27Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WJ. Severe axonal degeneration in acute Guillain–Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993; 116: 185–192. Medline
- 28 French Cooperative Group on Plasma Exchange in Guillain– Barré Syndrome. Efficiency of plasma exchange in Guillain– Barré syndrome: role of replacement fluids. Ann Neurol 1987; 22: 753–761. Medline
- 29 French Cooperative Group on Plasma Exchange in Guillain– Barré Syndrome. Appropriate number of plasma exchanges in Guillain–Barré syndrome. Ann Neurol 1997; 41: 298–306. Medline
- 30Fuller GN, Jacobs JM, Lewis PD, Lane RJM. Pseudoaxonal Guillain–Barré syndrome: severe demyelination mimicking axonopathy. J Neurol Neurosurg Psychiatry 1992; 55: 1079–1083. Medline
- 31Ganji S, Fraser E. Somatosensory evoked potential studies in acute Guillain–Barré syndrome. Electromyogr Clin Neurophysiol 1988; 28: 313–317. Medline
- 32Gilmore RL, Nelson KR. SSEP and F-wave studies in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1989: 12: 538–543. Medline
- 33Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol 1991; 30: 54–61. Medline
- 34 Guillain–Barré Syndrome Steroid Trial Group. Double-blind trial of intravenous methylprednisolone in Guillain–Barré syndrome. Lancet 1993; 341: 586–590. Medline
- 35Hall SM, Hughes RAC, Payan J, Atkinson PF, McColl I, Gale A. Motor nerve biopsy in severe Guillain–Barré syndrome. Ann Neurol 1992; 31: 441–444. Medline
- 36Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and the treatment of the Guillain–Barré syndrome—part I. Muscle Nerve 1995; 18: 137–153. Medline
- 37Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and the treatment of the Guillain–Barré syndrome—part II. Muscle Nerve 1995; 18: 154–164. Medline
- 38Harvey GK, Pollard JD. Patterns of conduction impairment in experimental allergic neuritis. An electrophysiological and histological study. J Neurol Neurosurg Psychiatry 1992; 55: 909–915. Medline
- 39Honavar M, Tharakan JKJ, Hughes RAC, Leibowitz S, Winer JB. A clinicopathological study of Guillain–Barré syndrome: nine cases and literature review. Brain 1991; 114: 1245–1270. Medline
- 40Hughes R, Swan A. Treatment of Guillain–Barré syndrome with intravenous methylprednisolone [letter]. Ann Neurol 1995; 37: 683. Medline
- 41Kelly JJ. The electrodiagnostic findings in the peripheral neuropathy associated with monoclonal gammopathy. Muscle Nerve 1983; 6: 504–509. Medline
- 42Kimura J. Proximal versus distal slowing of motor nerve conduction velocity in the Guillain–Barré syndrome. Ann Neurol 1978: 3: 344–350. Medline
- 43Kimura J, Sakimura S, Machida M, Fuchigami Y, Ishida T, Claus D, Kameyama S, Nakazium Y, Wang J, Yamada T. Effect of desynchronized inputs on compound sensory and motor action potentials. Muscle Nerve 1988; 11: 694–702 Medline
- 44Kurland LT, Wiederholt WC, Kirkpatrick JW, Potter HG, Armstrong P. Swine influenza vaccine and the Guillain–Barré syndrome. Epidemic or artifact? Arch Neurol 1985; 42: 1089–1090. Medline
- 45MacDonell RAL, Cros D, Shahani BT. Lumbosacral nerve root stimulation comparing electrical with surface magnetic coil techniques. Muscle Nerve 1992; 15: 885–890. Medline
- 46McKhann GM, Griffin JW, Cornblath DR, Mellitis ED, Fisher RS, Quaskey SA. Plasma exchange and the Guillain–Barré syndrome: analysis of prognostic features and the effect of plasma exchange. Ann Neurol 1988; 23: 347–353. Medline
- 47McLeod JG. Electrophysiological studies in the Guillain– Barré syndrome. Ann Neurol 1981; 9(suppl): 20–27. Medline
- 48Meulstee J, Van der Meche FGA, the Dutch Guillain– Barré Study Group. Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 1995; 59: 482–486. Medline
- 49Mills KR, Murphy NMF. Proximal conduction block in early Guillain–Barré syndrome. Lancet 1985; ii: 659
- 50Miller RG, Peterson GW, Daube JR, Albers JW. Prognostic value of electrodiagnosis in Guillain–Barré syndrome. Muscle Nerve 1988; 11: 769–774. Medline
- 51Miller RG, Peterson GW, Rosenberg NL. Electrophysiologic evidence of severe distal nerve segment pathology in the Guillain–Barré syndrome. Muscle Nerve 1987; 10: 524–529. Medline
- 52Moulin DE, Hagen N, Feasby TE, Amireh R, Hahn A. Pain in Guillain–Barré syndrome. Neurology 1997; 48: 328–331. Medline
- 53Olney RK, Aminoff MJ. Electrodiagnostic features of the Guillain–Barré syndrome: relative sensitivity of different techniques. Neurology 1990; 40: 471–475. Medline
- 54Olney RK, So YT, Goodin DS, Aminoff MJ. A comparison of magnetic and electrical stimulation of peripheral nerves. Muscle Nerve 1990; 13: 957–963. Medline
- 55Olsson Y. Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol 1968; 10: 26–33. Medline
- 56 Plasma Exchange/Sandoglobulin Guillain–Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain– Barré syndrome. Lancet 1997; 349: 225–230. Medline
- 57Rhee EK, Sumner AJ. A computer simulation of conduction block: effects produced by actual blocks versus interphase cancellation. Ann Neurol 1990; 28: 146–156. Medline
- 58Ropper AH. The Guillain–Barré syndrome. N Engl J Med 1992; 326: 1130–1136. Medline
- 59Ropper AH, Albers JW, Addison R. Limited relapse in Guillain–Barré syndrome after plasma exchange. Arch Neurol 1988; 45: 314–315. Medline
- 60Ropper AH, Chiappa KH. Evoked potentials in Guillain– Barré syndrome. Neurology 1986: 36: 587–590. Medline
- 61Ropper AH, Wijdicks EFM, Truax BT. Guillain–Barré Syndrome. Philadelphia: FA Davis Co; 1991. pp 28–30, 75–78, 86–87.
- 62Ropper AH, Wijdicks EFM. Blood pressure fluctuations in the dysautonomia of Guillain–Barré syndrome. Arch Neurol 1990; 47: 706–708. Medline
- 63Ropper AH, Wijdicks EFM, Shahani BT. Electrodiagnostic abnormalities in 113 consecutive patients with Guillain–Barré syndrome. Arch Neurol 1990; 47: 881–887. Medline
- 64Sumner AJ. Electrophysiology of the inflammatory demyelinating polyneuropathies. In: JG McLeod, editor. Baillière's clinical neurology. London: Baillière Tindall; 1994, vol 3(1). pp 25–43.
- 65Sumner AJ. The physiological basis for symptoms in Guillain– Barré syndrome. Ann Neurol 1981; 9(suppl): 28–30.
- 66 The Guillain–Barré Study Group. Effect of plasmaphoresis on the acute Guillain–Barré syndrome. Neurology 1985; 35: 1096–1104. Medline
- 67Triggs WJ, Cros D, Gominak SC, Zuniga G, Beric A, Shahani BT, Ropper AH, Roongta SM. Motor nerve inexcitability in Guillain–Barré syndrome. Brain 1992; 115: 1291–1302. Medline
- 68Van der Meche FGA. The Guillain–Barré syndrome. In: JG McLeod, editor. Baillière's clinical neurology. London: Baillière Tindall; 1994, vol 3(1). pp 73–93.
- 69Van der Meche FGA. Intravenous immune globulin in the Guillain–Barré syndrome. Clin Exp Immunol 1994; 97(suppl 1): 43–47. Medline
- 70Van der Meche FGA, Meulstee J, Kleyweg RP. Current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 1991; 30: 851–852.
- 71Van der Meche FGA, Meulstee J, Vermeulen M, Kievit A. Patterns of conduction failure in Guillain–Barré syndrome. Brain 1988; 111: 405–416. Medline
- 72Van der Meche FGA, Meulstee J. Guillain–Barré syndrome, a model for random conduction block. J Neurol Neurosurg Psychiatry 1988; 55: 1158–1163.
- 73Van der Meche FGA, Schmitz PIM, and the Dutch Guillain– Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain– Barré syndrome. N Engl J Med 1992; 326: 1123–1129. Medline
- 74Walsh JC, Yiannikias C, McLeod JG. Abnormalities of proximal conduction in acute idiopathic polyneuritis: comparison of short latency evoked potentials and F-waves. J Neurol Neurosurg Psychiatry 1984; 47: 197–200. Medline
- 75Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988; 51: 605–612. Medline
- 76Zifko U, Chen R, Remtulla H, Hahn AF, Koopman W, Bolton CF. Respiratory electrophysiological studies in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 1996; 60: 191–194. Medline
- 77Zochodne DW. Autonomic involvement in Guillain–Barré syndrome: a review. Muscle Nerve 1995; 17: 1145–1155.